Table of Contents Author Guidelines Submit a Manuscript
HPB Surgery
Volume 2014, Article ID 310372, 12 pages
http://dx.doi.org/10.1155/2014/310372
Research Article

Metabolomic Analysis of Liver Tissue from the VX2 Rabbit Model of Secondary Liver Tumors

1Departments of Surgery, Case Western Reserve University, School of Medicine and University Hospitals, Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA
2Departments of Nutrition, Case Western Reserve University, School of Medicine and University Hospitals, Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA
3Center for Proteomics and Bioinformatics, Case Western Reserve University, School of Medicine and University Hospitals, Case Medical Center, Cleveland, OH 44106, USA
4Department of Surgery, Cancer Treatment Centers of America, Chicago, IL 60099, USA

Received 29 October 2013; Revised 30 December 2013; Accepted 19 January 2014; Published 2 March 2014

Academic Editor: Harald Schrem

Copyright © 2014 R. Ibarra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Cancer,” Fact Sheet 297, 2009, http://www.who.int/mediacentre/factsheets/fs297/en/. View at Google Scholar
  2. M. Sherman, K. M. Peltekian, and C. Lee, “Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population,” Hepatology, vol. 22, no. 2, pp. 432–438, 1995. View at Google Scholar · View at Scopus
  3. R. Abbas, R. S. Kombu, R. A. Ibarra, K. K. Goyal, H. Brunengraber, and J. R. Sanabria, “The dynamics of glutathione species and ophthalmate concentrations in plasma from the VX2 rabbit model of secondary liver tumors,” HPB Surgery, vol. 2011, Article ID 709052, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Vinayavekhin, E. A. Homan, and A. Saghatelian, “Exploring disease through metabolomics,” ACS Chemical Biology, vol. 5, no. 1, pp. 91–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Ryan and K. Robards, “Metabolomics: the greatest omics of them all?” Analytical Chemistry, vol. 78, no. 23, pp. 7954–7958, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Griffin and R. A. Kauppinen, “Tumour metabolomics in animal models of human cancer,” Journal of Proteome Research, vol. 6, no. 2, pp. 498–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Griffin and J. P. Shockcor, “Metabolic profiles of cancer cells,” Nature Reviews Cancer, vol. 4, no. 7, pp. 551–561, 2004. View at Google Scholar · View at Scopus
  8. C. Yang, A. D. Richardson, J. W. Smith, and A. Osterman, “Comparative metabolomics of breast cancer,” Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, pp. 181–192, 2007. View at Google Scholar · View at Scopus
  9. P. Gao, C. Lu, F. Zhang et al., “Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis,” Analyst, vol. 133, no. 9, pp. 1214–1220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Tiziani, V. Lopes, and U. L. Günther, “Early stage diagnosis of oral cancer using 1H NMR-Based metabolomics1,2,” Neoplasia, vol. 11, no. 3, pp. 269–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Odunsi, R. M. Wollman, C. B. Ambrosone et al., “Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics,” International Journal of Cancer, vol. 113, no. 5, pp. 782–788, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Ippolito, J. Xu, S. Jain et al., “An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 28, pp. 9901–9906, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Wu, R. Xue, L. Dong et al., “Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry,” Analytica Chimica Acta, vol. 648, no. 1, pp. 98–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Gao, Q. Lu, X. Liu et al., “Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis,” Cancer Science, vol. 100, no. 4, pp. 782–785, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Yang, G. Xu, Y. Zheng et al., “Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases,” Journal of Chromatography B, vol. 813, no. 1-2, pp. 59–65, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Chen, W. Wang, S. Lv et al., “Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations,” Analytica Chimica Acta, vol. 650, no. 1, pp. 3–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Xue, Z. Lin, C. Deng et al., “A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 22, no. 19, pp. 3061–3068, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Á. D. Ortega, M. Sánchez-Aragó, D. Giner-Sánchez, L. Sánchez-Cenizo, I. Willers, and J. M. Cuezva, “Glucose avidity of carcinomas,” Cancer Letters, vol. 276, no. 2, pp. 125–135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Google Scholar · View at Scopus
  20. H. R. Christofk, M. G. Vander Heiden, M. H. Harris et al., “The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth,” Nature, vol. 452, no. 7184, pp. 230–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. D. Southam, J. M. Easton, G. D. Stentiford, C. Ludwig, T. N. Arvanitis, and M. R. Viant, “Metabolic changes in flatfish hepatic tumours revealed by NMR-based metabolomics and metabolic correlation networks,” Journal of Proteome Research, vol. 7, no. 12, pp. 5277–5285, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Yang, C. Li, X. Nie et al., “Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis,” Journal of Proteome Research, vol. 6, no. 7, pp. 2605–2614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. R. E. Shope and E. W. Hurst, “Infectious papillomatosis of rabbits: with a note on the histopathology,” The Journal of Experimental Medicine, vol. 58, pp. 607–624, 1933. View at Google Scholar
  24. J. H. Chen, Y. C. Lin, Y. S. Huang, T. J. Chen, W. Y. Lin, and K. W. Han, “Induction of VX2 carcinoma in rabbit liver: comparison of two inoculation methods,” Laboratory Animals, vol. 38, no. 1, pp. 79–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Liang, C.-S. Zheng, G.-S. Feng et al., “Correlation of hypoxia-inducible factor 1α with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model,” CardioVascular and Interventional Radiology, vol. 33, no. 4, pp. 806–812, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. B. D. Weinberg, E. Blanco, S. F. Lempka, J. M. Anderson, A. A. Exner, and J. Gao, “Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment,” Journal of Biomedical Materials Research A, vol. 81, no. 1, pp. 205–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Vali, J. A. Vossen, M. Buijs et al., “Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study,” Journal of Pharmacology and Experimental Therapeutics, vol. 327, no. 1, pp. 32–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Deng, S. Virmani, G.-Y. Yang et al., “Intraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors,” Journal of Magnetic Resonance Imaging, vol. 30, no. 2, pp. 366–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Rous, J. G. Kidd, and W. E. Smith, “Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. II. Loss by the Vx2 carcinoma of the power to immunize hosts against the papilloma virus,” The Journal of Experimental Medicine, vol. 96, pp. 159–174, 1952. View at Google Scholar
  30. M. P. Styczynski, J. F. Moxley, L. V. Tong, J. L. Walther, K. L. Jensen, and G. N. Stephanopoulos, “Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery,” Analytical Chemistry, vol. 79, no. 3, pp. 966–973, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J.-E. Dazard and J. Sunil Rao, “Joint adaptive meanvariance regularization and variance stabilization of high dimensional data,” Computational Statistics and Data Analysis, vol. 56, no. 7, pp. 2317–2333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-E. Dazard, H. Xu, and A. Santana, “MVR R package: mean variance regularization,” Comprehensive R Archive Network, 2011.
  33. B. Efron, “Robbins, empirical Bayes and microarrays,” The Annals of Statistics, vol. 31, no. 2, pp. 366–378, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Efron, R. Tibshirani, J. D. Storey, and V. Tusher, “Empirical bayes analysis of a microarray experiment,” Journal of the American Statistical Association, vol. 96, no. 456, pp. 1151–1160, 2001. View at Google Scholar · View at Scopus
  35. I. Lönnstedt, R. Rimini, and P. Nilsson, “Empirical bayes microarray ANOVA and grouping cell lines by equal expression levels,” Statistical Applications in Genetics and Molecular Biology, vol. 4, article 7, 2005. View at Google Scholar · View at Scopus
  36. M. A. Newton, C. M. Kendziorski, C. S. Richmond, F. R. Blattner, and K. W. Tsui, “On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data,” Journal of Computational Biology, vol. 8, no. 1, pp. 37–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. G. K. Smyth, “Linear models and empirical bayes methods for assessing differential expression in microarray experiments,” Statistical Applications in Genetics and Molecular Biology, vol. 3, no. 1, article 3, 2004. View at Google Scholar · View at Scopus
  38. C. M. Kendziorski, M. A. Newton, H. Lan, and M. N. Gould, “On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles,” Statistics in Medicine, vol. 22, no. 24, pp. 3899–3914, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. M. A. Newton, A. Noueiry, D. Sarkar, and P. Ahlquist, “Detecting differential gene expression with a semiparametric hierarchical mixture method,” Biostatistics, vol. 5, no. 2, pp. 155–176, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J. D. Storey, “The positive false discovery rate: a Bayesian interpretation and the q-value,” The Annals of Statistics, vol. 31, no. 6, pp. 2013–2035, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society, vol. 57, pp. 289–300, 1995. View at Google Scholar
  42. J. D. Storey, “A direct approach to false discovery rates,” Journal of the Royal Statistical Society B, vol. 64, no. 3, pp. 479–498, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Liu and J. T. G. Hwang, “Quick calculation for sample size while controlling false discovery rate with application to microarray analysis,” Bioinformatics, vol. 23, no. 6, pp. 739–746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. D. A. MacIntyre, B. Jiménez, E. J. Lewintre et al., “Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups,” Leukemia, vol. 24, no. 4, pp. 788–797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. R. Griffiths, P. M. J. McSheehy, S. P. Robinson et al., “Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1β (HIF-1β): evidence of an anabolic role for the HIF-1 pathway,” Cancer Research, vol. 62, no. 3, pp. 688–695, 2002. View at Google Scholar · View at Scopus
  46. Z.-F. Li, J. Wang, C. Huang et al., “Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis,” Rapid Communications in Mass Spectrometry, vol. 24, no. 18, pp. 2765–2775, 2010. View at Google Scholar · View at Scopus
  47. S. Pavlides, D. Whitaker-Menezes, R. Castello-Cros et al., “The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma,” Cell Cycle, vol. 8, no. 23, pp. 3984–4001, 2009. View at Google Scholar · View at Scopus
  48. G. Bonuccelli, A. Tsirigos, D. Whitaker-Menezes et al., “Ketones and lactate “fuel” tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism,” Cell Cycle, vol. 9, no. 17, pp. 3506–3514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. W. E. Gall, K. Beebe, K. A. Lawton et al., “α-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population,” PLoS ONE, vol. 5, no. 5, Article ID e10883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Biedroń, M. Ciszek, M. Tokarczyk et al., “1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages,” Archivum Immunologiae et Therapiae Experimentalis, vol. 56, no. 2, pp. 127–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Momchilova, T. Markovska, and R. Pankov, “Ha-ras-transformation alters the metabolism of phosphatidylethanolamine and phosphatidylcholine in NIH 3T3 fibroblasts,” Cell Biology International, vol. 23, no. 9, pp. 603–610, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Pumpo, G. Sarnelli, A. Spinella, G. Budillon, and R. Cuomo, “The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production,” American Journal of Gastroenterology, vol. 96, no. 4, pp. 1183–1187, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. B. R. Clark, J. T. Murai, and A. Pomeranz, “Altered distribution and excretion of N1 methylnicotinamide in rats with Walker 256 carcinosarcoma,” Cancer Research, vol. 35, no. 7, pp. 1727–1733, 1975. View at Google Scholar · View at Scopus
  54. J. R. Kuykendall, R. Cox, and D. Kinder, “1-Methylnicotinamide stimulates cell growth and inhibits hemoglobin synthesis in differentiating murine erythroleukemia cells,” Toxicology in Vitro, vol. 21, no. 8, pp. 1656–1662, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Chlopicki, J. Swies, A. Mogielnicki et al., “1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway,” British Journal of Pharmacology, vol. 152, no. 2, pp. 230–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Y. Minuk, “Gaba and hepatocellular carcinoma,” Molecular and Cellular Biochemistry, vol. 207, no. 1-2, pp. 105–108, 2000. View at Google Scholar · View at Scopus
  57. X. K. Zhang, T. Gauthier, F. J. Burczynski, G. Q. Wang, Y. Gong, and G. Y. Minuk, “Changes in liver membrane potentials after partial hepatectomy in rats,” Hepatology, vol. 23, no. 3, pp. 549–551, 1996. View at Google Scholar · View at Scopus
  58. G. Y. Minuk, M. Zhang, Y. Gong et al., “Decreased hepatocyte membrane potential differences and GABAA-β3 expression in human hepatocellular carcinoma,” Hepatology, vol. 45, no. 3, pp. 735–745, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. D. Sun, Y. Gong, H. Kojima et al., “Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 285, no. 1, pp. G12–G19, 2003. View at Google Scholar · View at Scopus
  60. M. Nakanishi and D. W. Rosenberg, “Roles of cPLA2α and arachidonic acid in cancer,” Biochimica et Biophysica Acta, vol. 1761, no. 11, pp. 1335–1343, 2006. View at Publisher · View at Google Scholar · View at Scopus